COVID-19 Vaccine

Bhubaneswar: Chief Minister Naveen Patnaik today said that people above sixty and pregnant mothers will get priority in COVID-19 vaccine distribution along with health workers in Odisha. The Chief Minister made this big announcement at a…

Cambridge: The US-based biotechnology company Moderna today said that its vaccine candidate was 94.5 per cent effective in preventing Covid-19 based on interim data from a late-stage clinical trial. The independent, NIH-appointed Data…

1. About 20 COVID-19 vaccines in different stages of developments in India: Vardhan 2. Kerala starts uploading data for Covid-19 vaccine shots 3. India may get 100 million doses of AstraZeneca's COVID-19 vaccine by Dec 2020 4. US aims to…

New Delhi: Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, and Indian Council of Medical Research (ICMR), the apex body in India for biomedical research, announced completion of enrolment of phase 3…

New York: Pfizer Inc and BioNTech SE yoday announced their mRNA based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection,…

Sydney: Australia has started locally manufacturing a COVID-19 vaccine candidate developed by the University of Oxford from Monday. Australian biotech firm CSL has confirmed it will commence manufacturing the University of…

1. Bharat Biotech's Covid vaccine Covaxin could be launched as early as February: Report 2. Private doctors on Maharashtra's Covid-19 vaccine priority list 3. Indian firm signs MoU with Bangladesh government for anti Covid vaccine…

New Delhi: India-made COVID vaccine ‘COVAXIN’ is likely to be launched by February next year, media reports stated citing ICRM officials. COVAXIN, an inactivated vaccine, is being developed by Hyderabad-based Bharat Biotech in…

New Delhi: The Serum Institute Of India has said that the potential Covid Vaccine Covishield could be available in India as early as January next year. SII which is working in collaboration with AstraZeneka on the Vaccine Development is in…

ପୁଣେ- ଅକ୍ସଫୋର୍ଡ ବିଶ୍ୱବିଦ୍ୟାଳୟ ଓ ଆଷ୍ଟ୍ରାଜେନେକା କଂପାନିର ମିଳିତ ଉଦ୍ୟମରେ ବିକଶିତ କରାଯାଉଥିବା କୋରୋନା ଟିକା ଭାରତରେ ଆସନ୍ତାବର୍ଷ ଜାନୁଆରୀରେ ଉପଲବ୍ଧ ହୋଇପାରେ । ଭାରତରେ ଏହି ଟିକା ପ୍ରସ୍ତୁତି ଦାୟିତ୍ୱରେ ଥିବା ସେରମ ଇନଷ୍ଟିଚ୍ୟୁଟ୍ ଅଫ୍ ଇଣ୍ଡିଆର ସିଇଓ ଆଦର ପୁନାୱାଲା କହିଛନ୍ତି…